Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Clinical and biological features of enteroviral meningitis among adults and children and factors associated with severity and length of stay.

Vareil M, Wille H, Kassab S, Le-Cornec C, Puges M, Desclaux A, Lafon ME, Tumiotto C, Cazanave C, Neau D.

J Clin Virol. 2018 Jul;104:56-60. doi: 10.1016/j.jcv.2018.04.017. Epub 2018 May 1.

PMID:
29738895
2.

Rapid Adenovirus typing method for species identification.

Rayne F, Wittkop L, Bader C, Kassab S, Tumiotto C, Berciaud S, Wodrich H, Lafon ME; Typadeno Study Members.

J Virol Methods. 2017 Nov;249:156-160. doi: 10.1016/j.jviromet.2017.09.009. Epub 2017 Sep 14.

PMID:
28918074
3.

Red palms associated with adenovirus gastroenteritis.

Chong JH, Mermin D, Marti A, Lafon ME, Dutkiewicz AS, Léauté-Labrèze C, Boralevi F.

Arch Dis Child. 2017 Sep;102(9):868-869. doi: 10.1136/archdischild-2016-312107. Epub 2017 Jan 12. No abstract available.

PMID:
28082320
4.

Epidemic of complicated mumps in previously vaccinated young adults in the South-West of France.

Vareil MO, Rouibi G, Kassab S, Soula V, Duffau P, Lafon ME, Neau D, Cazanave C.

Med Mal Infect. 2014 Dec;44(11-12):502-8. doi: 10.1016/j.medmal.2014.09.006. Epub 2014 Oct 25.

PMID:
25391635
5.

Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema.

Hubiche T, Schuffenecker I, Boralevi F, Léauté-Labrèze C, Bornebusch L, Chiaverini C, Phan A, Maruani A, Miquel J, Lafon ME, Lina B, Del Giudice P; Clinical Research Group of the French Society of Pediatric Dermatology Groupe de Recherche Clinique de la Société Française de Dermatologie Pédiatrique.

Pediatr Infect Dis J. 2014 Apr;33(4):e92-8. doi: 10.1097/INF.0000000000000120.

PMID:
24463804
6.

Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012.

Kassab S, Saghi T, Boyer A, Lafon ME, Gruson D, Lina B, Fleury H, Schuffenecker I.

Emerg Infect Dis. 2013 Aug;19(8):1345-7. doi: 10.3201/eid1908.130202. No abstract available.

7.

Preemptive therapy versus valgancyclovir prophylaxis in cytomegalovirus-positive kidney transplant recipients receiving antithymocyte globulin induction.

Couzi L, Helou S, Bachelet T, Martin S, Moreau K, Morel D, Lafon ME, Garrigue I, Merville P.

Transplant Proc. 2012 Nov;44(9):2809-13. doi: 10.1016/j.transproceed.2012.09.029.

PMID:
23146529
8.

Adenovirus infections in Bordeaux University Hospital 2008-2010: clinical and virological features.

Berciaud S, Rayne F, Kassab S, Jubert C, Faure-Della Corte M, Salin F, Wodrich H, Lafon ME; Typadeno Study Members.

J Clin Virol. 2012 Aug;54(4):302-7. doi: 10.1016/j.jcv.2012.04.009. Epub 2012 May 17.

PMID:
22608365
9.

High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapy.

Couzi L, Helou S, Bachelet T, Moreau K, Martin S, Morel D, Lafon ME, Boyer B, Alain S, Garrigue I, Merville P.

Am J Transplant. 2012 Jan;12(1):202-9. doi: 10.1111/j.1600-6143.2011.03766.x. Epub 2011 Oct 3.

10.

CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007.

Bruyand M, Vandenhende MA, Marcel G, Lazaro E, Lafon ME, Dupon M, Dabis F, Geffard S, Fleury H, Faure-Della Corte M, Bonnet F, Thiebaut R, Garrigue I.

J Clin Virol. 2011 Feb;50(2):177-80. doi: 10.1016/j.jcv.2010.10.021. Epub 2010 Dec 3.

PMID:
21126905
11.

Lymphoepithelioma-like carcinoma of the ovary: a case report and review of the literature.

Brun JL, Randriambelomanana J, Cherier L, Lafon ME, Trufflandier N, Le Bail B.

Int J Gynecol Pathol. 2010 Sep;29(5):427-31. doi: 10.1097/PGP.0b013e3181db69da. Review.

PMID:
20736767
12.

[Persistent influenza virus infection in a patient treated with alemtuzumab].

Burrel S, Dilhuydy S, Bouabdallah K, Lafon MÉ, Milpied N, Fleury H.

Med Mal Infect. 2010 Nov;40(11):657-9. doi: 10.1016/j.medmal.2010.03.001. Epub 2010 Jul 16. French. No abstract available.

PMID:
20638206
13.

Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients.

Pistone T, Verdière CH, Receveur MC, Ezzedine K, Lafon ME, Malvy D.

Curr HIV Res. 2010 Sep;8(6):461-6.

PMID:
20636276
14.

Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients.

Faure-Della Corte M, Samot J, Garrigue I, Magnin N, Reigadas S, Couzi L, Dromer C, Velly JF, Déchanet-Merville J, Fleury HJ, Lafon ME.

J Clin Virol. 2010 Feb;47(2):161-9. doi: 10.1016/j.jcv.2009.11.023.

PMID:
20022297
15.
16.

Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients.

Couzi L, Pitard V, Netzer S, Garrigue I, Lafon ME, Moreau JF, Taupin JL, Merville P, Déchanet-Merville J.

J Infect Dis. 2009 Nov 1;200(9):1415-24. doi: 10.1086/644509.

PMID:
19780672
17.

Cluster of chikungunya virus infection in travelers returning from Senegal, 2006.

Pistone T, Ezzedine K, Boisvert M, Receveur MC, Schuffenecker I, Zeller H, Lafon ME, Fleury H, Malvy D.

J Travel Med. 2009 Jul-Aug;16(4):286-8. doi: 10.1111/j.1708-8305.2008.00294.x.

18.

Epstein-Barr virus load in whole blood correlates with HIV surrogate markers and lymphoma: a French national cross-sectional study.

Amiel C, Legoff J, Lescure FX, Coste-Burel M, Deback C, Fafi-Kremer S, Gueudin M, Lafon ME, Leruez-Ville M, Mengelle C, Payan C, Pillet S.

J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):427-9. doi: 10.1097/QAI.0b013e31819a22ec. No abstract available.

PMID:
19322036
19.

UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients.

Garrigue I, Faure-Della Corte M, Magnin N, Recordon-Pinson P, Couzi L, Lebrette ME, Schrive MH, Roncin L, Taupin JL, Déchanet-Merville J, Fleury H, Lafon ME.

Transplantation. 2008 Sep 27;86(6):826-35. doi: 10.1097/TP.0b013e3181859edd.

PMID:
18813108
20.

Occult hepatitis B in HIV-HCV coinfected patients.

Piroth L, Lafon ME, Binquet C, Bertillon P, Gervais A, Lootvoet E, Lang JM, De Jaureguiberry JP, Chene G, Leport C; ANRS CO8 APROCO-COPILOTE Study Group.

Scand J Infect Dis. 2008;40(10):835-9. doi: 10.1080/00365540801918511.

PMID:
18609222
21.

Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection.

Pitard V, Roumanes D, Lafarge X, Couzi L, Garrigue I, Lafon ME, Merville P, Moreau JF, Déchanet-Merville J.

Blood. 2008 Aug 15;112(4):1317-24. doi: 10.1182/blood-2008-01-136713. Epub 2008 Jun 6.

22.

Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort.

Neau D, Trimoulet P, Pereira E, Lafon ME, Gervais A, Ragnaud JM, Dupon M, Ecobichon JL, Chêne G, Raffi F; ANRS CO8 APROCO-COPILOTE Study Group.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):227-9. doi: 10.1097/QAI.0b013e31816d9cc3. No abstract available.

PMID:
18520685
23.

Tickborne encephalitis, southwestern France.

Herpe B, Schuffenecker I, Pillot J, Malvy D, Clouzeau B, Bui N, Vargas F, Gruson D, Zeller H, Lafon ME, Fleury H, Hilbert G.

Emerg Infect Dis. 2007 Jul;13(7):1114-6. doi: 10.3201/eid1307.070041.

24.

Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.

Trimoulet P, Boutonnet M, Winnock M, Faure M, Loko MA, De Lédinghen V, Bernard PH, Castéra L, Foucher J, Dupon M, Ragnaud JM, Lafon ME, Couzigou P, Dabis F, Fleury H, Neau D.

Gastroenterol Clin Biol. 2007 Dec;31(12):1088-94.

25.

Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients.

Garrigue I, Doussau A, Asselineau J, Bricout H, Couzi L, Rio C, Merville P, Fleury H, Lafon ME, Thiébaut R.

J Clin Microbiol. 2008 Feb;46(2):493-8. Epub 2007 Dec 5.

26.

Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients.

Garrigue I, Corte MF, Magnin N, Couzi L, Capdepont S, Rio C, Merville P, Dechanet-Merville J, Fleury H, Lafon ME.

J Clin Virol. 2007 Oct;40(2):120-8. Epub 2007 Sep 10.

PMID:
17827058
27.

Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort.

Neau D, Winnock M, Castéra L, Bail BL, Loko MA, Géraut L, Dupon M, Ragnaud JM, Lacoste D, Lafon ME, Bioulac-Sage P, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):168-73.

PMID:
17527092
28.

Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis.

Viallard JF, Lazaro E, Ellie E, Eimer S, Camou F, Caubet O, Lafon ME, Fleury H, Pellegrin JL.

Infection. 2007 Feb;35(1):33-6.

PMID:
17297588
29.

Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study.

Castéra L, Pedeboscq A, Rocha M, Le Bail B, Asencio C, de Lédinghen V, Bernard PH, Laurent C, Lafon ME, Capdepont M, Couzigou P, Bioulac-Sage P, Balabaud C, Mégraud F, Ménard A.

World J Gastroenterol. 2006 Dec 7;12(45):7278-84.

30.

[A case of severe community acquired pneumonia and non-respiratory illness induced by Influenza A].

Duffau P, Moiton MP, Lafon ME, Braun C, Neau D, Ragnaud JM.

Med Mal Infect. 2006 Sep;36(9):473-5. Epub 2006 Oct 4. French.

PMID:
17027214
31.

A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.

Bonnet F, Jouvencel AC, Parrens M, Leon MJ, Cotto E, Garrigue I, Morlat P, Beylot J, Fleury H, Lafon ME.

J Clin Virol. 2006 Aug;36(4):258-63. Epub 2006 Jun 9.

PMID:
16762591
32.

Plasma and liver hepatitis C virus variability in patients coinfected with human immunodeficiency virus.

Jouvencel AC, Neau D, Faure M, Neau M, Martinaud C, Legrand E, Trimoulet P, Garrigue I, Le Bail B, Bioulac-Sage P, Dupon M, Ragnaud JM, Fleury H, Lafon ME.

J Clin Microbiol. 2006 May;44(5):1877-80.

33.

Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.

Garrigue I, Boucher S, Couzi L, Caumont A, Dromer C, Neau-Cransac M, Tabrizi R, Schrive MH, Fleury H, Lafon ME.

J Clin Virol. 2006 May;36(1):72-5. Epub 2006 Feb 14.

PMID:
16481215
34.

JC virus meningitis in a patient with systemic lupus erythematosus.

Viallard JF, Ellie E, Lazaro E, Lafon ME, Pellegrin JL.

Lupus. 2005;14(12):964-6.

PMID:
16425577
35.

Successful cidofovir therapy of progressive multifocal leukoencephalopathy preceding angioimmunoblastic T-cell lymphoma.

Viallard JF, Lazaro E, Lafon ME, Pellegrin JL.

Leuk Lymphoma. 2005 Nov;46(11):1659-62.

PMID:
16334909
36.

[Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up].

Seydi M, Morlat P, Bonnet F, Rambeloarisoa J, Bernard N, Lacoste D, Bonarek M, Trimoulet P, Ramanampamonjy R, Lafon ME, Dramé M, Beylot J.

Rev Med Interne. 2005 Apr;26(4):280-7. French.

PMID:
15820563
37.

Modifications of T-lymphocyte subsets before and during interferon and ribavirin treatment for chronic hepatitis C infection.

Neau-Cransac M, Foucher J, Ledinghen VD, Bernard PH, Legrand E, Lafon ME.

Viral Immunol. 2005;18(1):197-204.

PMID:
15802964
38.

Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.

Neau D, Winnock M, Jouvencel AC, Faure M, Castéra L, Legrand E, Lacoste D, Ragnaud JM, Dupon M, Fleury H, Lafon ME, Dabis F; Groupe d'Epidemiologie Clinique du SIDA en Aquitaine.

Clin Infect Dis. 2005 Mar 1;40(5):750-3. Epub 2005 Jan 28.

PMID:
15714424
39.

New insights in HTLV-I phylogeny by sequencing and analyzing the entire envelope gene.

Capdepont S, Londos-Gagliardi D, Joubert M, Correze P, Lafon ME, Guillemain B, Fleury HJ.

AIDS Res Hum Retroviruses. 2005 Jan;21(1):28-42.

PMID:
15665642
40.

Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutations.

Deshpande A, Recordon-Pinson P, Deshmukh R, Faure M, Jauvin V, Garrigue I, Lafon ME, Fleury HJ.

AIDS Res Hum Retroviruses. 2004 Sep;20(9):1032-5.

PMID:
15585093
41.

[Severe acute respiratory syndrome: one case of indirect transmission by Coronavirus].

Dutronc H, Dupon M, Cipriano G, Lafarie S, Lafon ME, Fleury HJ, Bocquentin F, Neau D, Ragnaud JM.

Rev Med Interne. 2004 Aug;25(8):607-9. French. No abstract available.

PMID:
15276297
42.

Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.

Neau D, Winnock M, Galpérine T, Jouvencel AC, Castéra L, Legrand E, Tranchant E, Balestre E, Lacoste D, Ragnaud JM, Dupon M, Lafon ME, Dabis F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

HIV Med. 2004 May;5(3):171-3.

43.

Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.

Danve-Szatanek C, Aymard M, Thouvenot D, Morfin F, Agius G, Bertin I, Billaudel S, Chanzy B, Coste-Burel M, Finkielsztejn L, Fleury H, Hadou T, Henquell C, Lafeuille H, Lafon ME, Le Faou A, Legrand MC, Maille L, Mengelle C, Morand P, Morinet F, Nicand E, Omar S, Picard B, Pozzetto B, Puel J, Raoult D, Scieux C, Segondy M, Seigneurin JM, Teyssou R, Zandotti C.

J Clin Microbiol. 2004 Jan;42(1):242-9.

44.

Borna disease virus RNA in immunocompromised patients in southwestern France.

Cotto E, Neau D, Cransac-Neau M, Auriacombe M, Pellegrin JL, Ragnaud JM, Fillet AM, Belnard M, Fleury H, Lafon ME.

J Clin Microbiol. 2003 Dec;41(12):5577-81.

45.

HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs.

Lan NT, Recordon-Pinson P, Hung PV, Uyen NT, Lien TT, Tien HT, Garrigue I, Schrive MH, Pellegrin I, Lafon ME, Aboulker JP, Barré-Sinousi F, Fleury HJ.

AIDS Res Hum Retroviruses. 2003 Oct;19(10):925-8.

PMID:
14601592
46.

Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Côte d'Ivoire: ANRS 1257 study.

Toni TD, Recordon-Pinson P, Minga A, Ekouevi D, Bonard D, Bequet L, Huet C, Chenal H, Rouet F, Dabis F, Lafon ME, Salamon R, Masquelier B, Fleury HJ.

AIDS Res Hum Retroviruses. 2003 Aug;19(8):713-7.

PMID:
14506786
47.

Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.

Neau D, Jouvencel AC, Legrand E, Trimoulet P, Galperine T, Chitty I, Ventura M, Le Bail B, Morlat P, Lacut JY, Ragnaud JM, Dupon M, Fleury H, Lafon ME.

J Med Virol. 2003 Sep;71(1):41-8.

PMID:
12858407
48.

Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients.

Neau D, Trimoulet P, Winnock M, Rullier A, Le Bail B, Lacoste D, Ragnaud JM, Bioulac-Sage P, Lafon ME, Chêne G, Dupon M; ROCO Study Group.

Clin Infect Dis. 2003 Jun 15;36(12):1564-71. Epub 2003 Jun 3.

PMID:
12802757
49.

T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin.

Neau D, Galpérine T, Legrand E, Pitard V, Neau-Cransac M, Moreau JF, Ragnaud JM, Dupon M, Fleury H, Lafon ME.

HIV Med. 2003 Apr;4(2):120-6.

50.

Severe prolonged red blood cell aplasia and thrombocytopenia induced by parvovirus B19 infection in a patient with sarcoidosis.

Viallard JF, Parrens M, Hermine O, Boiron JM, Lafon ME, Marit G, Reiffers J, Pellegrin JL.

Clin Infect Dis. 2003 Jan 15;36(2):229-33. Epub 2003 Jan 6.

PMID:
12522758

Supplemental Content

Loading ...
Support Center